Reports — Most-Cited Articles as of March 1, 2018 -- updated monthly

- C J Powers,
- S W McLeskey,
- and A Wellstein
Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 7 (3) 165-97, doi:10.1677/erc.0.0070165
- Abstract
- Full Text (PDF)
- N Prenzel,
- O M Fischer,
- S Streit,
- S Hart,
- and A Ullrich
The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocr Relat Cancer 8 (1) 11-31, doi:10.1677/erc.0.0080011
- Abstract
- Full Text (PDF)
Reviews:
- M Xing
BRAF mutation in thyroid cancer Endocr Relat Cancer 12 (2) 245-262, doi:10.1677/erc.1.0978
- K Yu,
- L Toral-Barza,
- C Discafani,
- W G Zhang,
- J Skotnicki,
- P Frost,
- and J J Gibbons
mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer. Endocr Relat Cancer 8 (3) 249-58, doi:10.1677/erc.0.0080249
- Abstract
- Full Text (PDF)
- J F Lyons,
- S Wilhelm,
- B Hibner,
- and G Bollag
Discovery of a novel Raf kinase inhibitor. Endocr Relat Cancer 8 (3) 219-25, doi:10.1677/erc.0.0080219
- Abstract
- Full Text (PDF)
Research:
- P Pallante,
- R Visone,
- M Ferracin,
- A Ferraro,
- M T Berlingieri,
- G Troncone,
- G Chiappetta,
- C G Liu,
- M Santoro,
- M Negrini,
- C M Croce,
- and A Fusco
MicroRNA deregulation in human thyroid papillary carcinomas Endocr Relat Cancer 13 (2) 497-508, doi:10.1677/erc.1.01209
Reviews:
- Alistair Ring and
- Mitch Dowsett
Mechanisms of tamoxifen resistance Endocr Relat Cancer 11 (4) 643-658, doi:10.1677/erc.1.00776
Original Research:
- R Kaaks,
- S Rinaldi,
- T J Key,
- F Berrino,
- P H M Peeters,
- C Biessy,
- L Dossus,
- A Lukanova,
- S Bingham,
- K-T Khaw,
- N E Allen,
- H B Bueno-de-Mesquita,
- C H van Gils,
- D Grobbee,
- H Boeing,
- P H Lahmann,
- G Nagel,
- J Chang-Claude,
- F Clavel-Chapelon,
- A Fournier,
- A Thiébaut,
- C A González,
- J R Quirós,
- M-J Tormo,
- E Ardanaz,
- P Amiano,
- V Krogh,
- D Palli,
- S Panico,
- R Tumino,
- P Vineis,
- A Trichopoulou,
- V Kalapothaki,
- D Trichopoulos,
- P Ferrari,
- T Norat,
- R Saracci,
- and E Riboli
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition Endocr Relat Cancer 12 (4) 1071-1082, doi:10.1677/erc.1.01038
- D Sachdev and
- D Yee
The IGF system and breast cancer. Endocr Relat Cancer 8 (3) 197-209, doi:10.1677/erc.0.0080197
- Abstract
- Full Text (PDF)
Review:
- Paolo Vigneri,
- Francesco Frasca,
- Laura Sciacca,
- Giuseppe Pandini,
- and Riccardo Vigneri
Diabetes and cancer Endocr Relat Cancer 16 (4) 1103-1123, doi:10.1677/ERC-09-0087 first published on 20 July 2009
Original Research:
- H E Jones,
- L Goddard,
- J M W Gee,
- S Hiscox,
- M Rubini,
- D Barrow,
- J M Knowlden,
- S Williams,
- A E Wakeling,
- and R I Nicholson
Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells Endocr Relat Cancer 11 (4) 793-814, doi:10.1677/erc.1.00799
Reviews:
- Howard I Scher,
- Grant Buchanan,
- William Gerald,
- Lisa M Butler,
- and Wayne D Tilley
Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer Endocr Relat Cancer 11 (3) 459-476, doi:10.1677/erc.1.00525
- S F Doisneau-Sixou,
- C M Sergio,
- J S Carroll,
- R Hui,
- E A Musgrove,
- and R L Sutherland
Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells. Endocr Relat Cancer 10 (2) 179-86, doi:10.1677/erc.0.0100179
- Abstract
- Full Text (PDF)
Original Research:
- A Bardin,
- N Boulle,
- G Lazennec,
- F Vignon,
- and P Pujol
Loss of ERβ expression as a common step in estrogen-dependent tumor progression Endocr Relat Cancer 11 (3) 537-551, doi:10.1677/erc.1.00800
- R I Nicholson,
- R A McClelland,
- J F Robertson,
- and J M Gee
Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer. Endocr Relat Cancer 6 (3) 373-87, doi:10.1677/erc.0.0060373
- Abstract
- Full Text (PDF)
Research:
- Rosa Visone,
- Lucia Russo,
- Pierlorenzo Pallante,
- Ivana De Martino,
- Angelo Ferraro,
- Vincenza Leone,
- Eleonora Borbone,
- Fabio Petrocca,
- Hansjuerg Alder,
- Carlo Maria Croce,
- and Alfredo Fusco
MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27^Kip1 protein levels and cell cycle Endocr Relat Cancer 14 (3) 791-798, doi:10.1677/ERC-07-0129
Regular papers:
- Balázs Győrffy,
- András Lánczky,
- and Zoltán Szállási
Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients Endocr Relat Cancer 19 (2) 197-208, doi:10.1530/ERC-11-0329 first published on 25 January 2012
- L R Howe,
- K Subbaramaiah,
- A M Brown,
- and A J Dannenberg
Cyclooxygenase-2: a target for the prevention and treatment of breast cancer. Endocr Relat Cancer 8 (2) 97-114, doi:10.1677/erc.0.0080097
- Abstract
- Full Text (PDF)
Focus Review:
- Benjamin Boyerinas,
- Sun-Mi Park,
- Annika Hau,
- Andrea E Murmann,
- and Marcus E Peter
The role of let-7 in cell differentiation and cancer Endocr Relat Cancer 17 (1) F19-F36, doi:10.1677/ERC-09-0184 first published on 24 September 2009
- K W Colston and
- C M√∏rk Hansen
Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr Relat Cancer 9 (1) 45-59, doi:10.1677/erc.0.0090045
- Abstract
- Full Text (PDF)
Research:
- Xiaoli Liu,
- Justin Bishop,
- Yuan Shan,
- Sara Pai,
- Dingxie Liu,
- Avaniyapuram Kannan Murugan,
- Hui Sun,
- Adel K El-Naggar,
- and Mingzhao Xing
Highly prevalent TERT promoter mutations in aggressive thyroid cancers Endocr Relat Cancer 20 (4) 603-610, doi:10.1530/ERC-13-0210 first published on 13 June 2013
- J Mendelsohn
The epidermal growth factor receptor as a target for cancer therapy. Endocr Relat Cancer 8 (1) 3-9, doi:10.1677/erc.0.0080003
- Abstract
- Full Text (PDF)
Reviews:
- B Kwabi-Addo,
- M Ozen,
- and M Ittmann
The role of fibroblast growth factors and their receptors in prostate cancer Endocr Relat Cancer 11 (4) 709-724, doi:10.1677/erc.1.00535
- D C Allred,
- S K Mohsin,
- and S A Fuqua
Histological and biological evolution of human premalignant breast disease. Endocr Relat Cancer 8 (1) 47-61, doi:10.1677/erc.0.0080047
- Abstract
- Full Text (PDF)
- N Normanno,
- C Bianco,
- A De Luca,
- M R Maiello,
- and D S Salomon
Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment. Endocr Relat Cancer 10 (1) 1-21, doi:10.1677/erc.0.0100001
- Abstract
- Full Text (PDF)
- P L Dahia
PTEN, a unique tumor suppressor gene. Endocr Relat Cancer 7 (2) 115-29, doi:10.1677/erc.0.0070115
- Abstract
- Full Text (PDF)
Research:
- G Riesco-Eizaguirre,
- P Gutiérrez-Martínez,
- M A García-Cabezas,
- M Nistal,
- and P Santisteban
The oncogene BRAF^V600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na⁺/I⁻ targeting to the membrane Endocr Relat Cancer 13 (1) 257-269, doi:10.1677/erc.1.01119
- D J Liao and
- R B Dickson
c-Myc in breast cancer. Endocr Relat Cancer 7 (3) 143-64, doi:10.1677/erc.0.0070143
- Abstract
- Full Text (PDF)
Reviews:
- Nicola Normanno,
- Massimo Di Maio,
- Ermelinda De Maio,
- Antonella De Luca,
- Andrea de Matteis,
- Antonio Giordano,
- Francesco Perrone,
- and on behalf of the NCI-Naples Breast Cancer Group
- , on behalf of the NCI-Naples Breast Cancer Group
Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer Endocr Relat Cancer 12 (4) 721-747, doi:10.1677/erc.1.00857
Reviews:
- Rossella Libè,
- Amato Fratticci,
- and Jérôme Bertherat
Adrenocortical cancer: pathophysiology and clinical management Endocr Relat Cancer 14 (1) 13-28, doi:10.1677/erc.1.01130
Reviews:
- Linda Vona-Davis and
- David P Rose
Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression Endocr Relat Cancer 14 (2) 189-206, doi:10.1677/ERC-06-0068
Review:
- Scott M Dehm and
- Donald J Tindall
Alternatively spliced androgen receptor variants Endocr Relat Cancer 18 (5) R183-R196, doi:10.1530/ERC-11-0141 first published on 21 July 2011
Original Research:
- D E Schteingart,
- G M Doherty,
- P G Gauger,
- T J Giordano,
- G D Hammer,
- M Korobkin,
- and F P Worden
Management of patients with adrenal cancer: recommendations of an international consensus conference Endocr Relat Cancer 12 (3) 667-680, doi:10.1677/erc.1.01029
Original Research:
- Francesco Panzuto,
- Silvia Nasoni,
- Massimo Falconi,
- Vito Domenico Corleto,
- Gabriele Capurso,
- Sara Cassetta,
- Michela Di Fonzo,
- Valentina Tornatore,
- Massimo Milione,
- Stefano Angeletti,
- Maria Sofia Cattaruzza,
- Vincenzo Ziparo,
- Cesare Bordi,
- Paolo Pederzoli,
- and Gianfranco Delle Fave
Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization Endocr Relat Cancer 12 (4) 1083-1092, doi:10.1677/erc.1.01017
Original Research:
- Alfredo Berruti,
- Massimo Terzolo,
- Paola Sperone,
- Anna Pia,
- Silvia Della Casa,
- David J Gross,
- Carlo Carnaghi,
- Paolo Casali,
- Francesco Porpiglia,
- Franco Mantero,
- Giuseppe Reimondo,
- Alberto Angeli,
- and Luigi Dogliotti
Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial Endocr Relat Cancer 12 (3) 657-666, doi:10.1677/erc.1.01025
- C T Kuan,
- C J Wikstrand,
- and D D Bigner
EGF mutant receptor vIII as a molecular target in cancer therapy. Endocr Relat Cancer 8 (2) 83-96, doi:10.1677/erc.0.0080083
- Full Text (PDF)
Reviews:
- A M Lorincz and
- S Sukumar
Molecular links between obesity and breast cancer Endocr Relat Cancer 13 (2) 279-292, doi:10.1677/erc.1.00729
- R I Nicholson,
- I R Hutcheson,
- M E Harper,
- J M Knowlden,
- D Barrow,
- R A McClelland,
- H E Jones,
- A E Wakeling,
- and J M Gee
Modulation of epidermal growth factor receptor in endocrine-resistant, oestrogen receptor-positive breast cancer. Endocr Relat Cancer 8 (3) 175-82, doi:10.1677/erc.0.0080175
- Abstract
- Full Text (PDF)
- M Dowsett
Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer. Endocr Relat Cancer 8 (3) 191-5, doi:10.1677/erc.0.0080191
- Abstract
- Full Text (PDF)
Reviews:
- Graeme Eisenhofer,
- Stefan R Bornstein,
- Frederieke M Brouwers,
- Nai-Kong V Cheung,
- Patricia L Dahia,
- Ronald R de Krijger,
- Thomas J Giordano,
- Lloyd A Greene,
- David S Goldstein,
- Hendrik Lehnert,
- William M Manger,
- John M Maris,
- Hartmut P H Neumann,
- Karel Pacak,
- Barry L Shulkin,
- David I Smith,
- Arthur S Tischler,
- and William F Young, Jr
Malignant pheochromocytoma: current status and initiatives for future progress Endocr Relat Cancer 11 (3) 423-436, doi:10.1677/erc.1.00829
Research:
- S Tozlu,
- I Girault,
- S Vacher,
- J Vendrell,
- C Andrieu,
- F Spyratos,
- P Cohen,
- R Lidereau,
- and I Bieche
Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach Endocr Relat Cancer 13 (4) 1109-1120, doi:10.1677/erc.1.01120
Review:
- Robert C Smallridge,
- Laura A Marlow,
- and John A Copland
Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies Endocr Relat Cancer 16 (1) 17-44, doi:10.1677/ERC-08-0154 first published on 5 November 2008
Reviews:
- Marc Lacroix,
- Robert-Alain Toillon,
- and Guy Leclercq
p53 and breast cancer, an update Endocr Relat Cancer 13 (2) 293-325, doi:10.1677/erc.1.01172
- J T Arnold and
- J T Isaacs
Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault. Endocr Relat Cancer 9 (1) 61-73, doi:10.1677/erc.0.0090061
- Abstract
- Full Text (PDF)
- M D Sadar,
- M Hussain,
- and N Bruchovsky
Prostate cancer: molecular biology of early progression to androgen independence. Endocr Relat Cancer 6 (4) 487-502, doi:10.1677/erc.0.0060487
- Abstract
- Full Text (PDF)
- C Palmieri,
- G J Cheng,
- S Saji,
- M Zelada-Hedman,
- A W√§rri,
- Z Weihua,
- S Van Noorden,
- T Wahlstrom,
- R C Coombes,
- M Warner,
- and J-A Gustafsson
Estrogen receptor beta in breast cancer. Endocr Relat Cancer 9 (1) 1-13, doi:10.1677/erc.0.0090001
- Abstract
- Full Text (PDF)
- P A Abrahamsson
Neuroendocrine cells in tumour growth of the prostate. Endocr Relat Cancer 6 (4) 503-19, doi:10.1677/erc.0.0060503
- Abstract
- Full Text (PDF)
Review:
- Jenny Welander,
- Peter Söderkvist,
- and Oliver Gimm
Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas Endocr Relat Cancer 18 (6) R253-R276, doi:10.1530/ERC-11-0170 first published on 31 October 2011
- Z Culig,
- H Klocker,
- G Bartsch,
- and A Hobisch
Androgen receptors in prostate cancer. Endocr Relat Cancer 9 (3) 155-70, doi:10.1677/erc.0.0090155
- Abstract
- Full Text (PDF)
Conference Papers:
- J M Gee,
- J F Robertson,
- E Gutteridge,
- I O Ellis,
- S E Pinder,
- M Rubini,
- and R I Nicholson
Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer Endocr Relat Cancer 12 (Supplement 1) S99-S111, doi:10.1677/erc.1.01005

New Articles: issue in progress

May 2018, 25 (5)

Tweets by @EndoCancer

Endocrine-Related Cancer

Most-Cited Articles as of March 1, 2018 -- updated monthly

New Articles: issue in progress

Most

Viewed

Cited